A phase 2 study of immunogenic cell death inducer PT-112 in patients with metastatic castration-resistant prostate cancer.

被引：0
|
作者：
Bryce, Alan Haruo
Karp, Daniel D.
Tagawa, Scott T.
Nordquist, Luke T.
Rathkopf, Dana E.
Adra, Nabil
Dorff, Tanya B.
Baeck, Johan
O'Donnell, Joseph Francis
Ames, Tyler David
Yim, Christina Y.
Price, Matthew
Scher, Howard I.
机构：
[1] Mayo Clin, Phoenix, AZ USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Cornell Univ, Weill Cornell Med Coll, New York, NY USA
[4] Urol Canc Ctr PC, Omaha, NE USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY USA
[6] Weill Cornell Med, New York, NY USA
[7] Indiana Univ, Simon Comprehens Canc Ctr, Indianapolis, IN USA
[8] City Hope Natl Med Ctr, Duarte, CA USA
[9] Promontory Therapeut Inc, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS292
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II cohort study in patients with metastatic castration-resistant prostate cancer (mCRPC) with new cohorts
    Rexer, Heidrun
    Retz, Margitta
    Hammerer, Peter
    AKTUELLE UROLOGIE, 2022, 53 (06) : 504 - 505
  • [42] Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer
    Lin, Jianqing
    Elkon, Jacob
    Ricart, Brittany
    Palmer, Erica
    Zevallos-Delgado, Christian
    Noonepalle, Satish
    Burgess, Brooke
    Siegel, Robert
    Ma, Yan
    Villagra, Alejandro
    ONCOLOGIST, 2021, 26 (12) : E2136 - E2142
  • [43] SPOP mutation as a predictive marker for treatment of metastatic castration-resistant prostate cancer.
    Stangl, Andrew
    Willner, Christopher
    Maahs, Lucas
    Burmeister, Charlotte
    Hwang, Clara
    Pilling, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [44] Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
    Petrylak, Daniel P.
    Loriot, Yohann
    Shaffer, David R.
    Braiteh, Fadi
    Powderly, John
    Harshman, Lauren C.
    Conkling, Paul
    Delord, Jean-Pierre
    Gordon, Michael
    Kim, Joseph W.
    Sarkar, Indrani
    Yuen, Kobe
    Kadel, Edward E.
    Mariathasan, Sanjeev
    O'Hear, Carol
    Narayanan, Sujata
    Fasso, Marcella
    Carroll, Susheela
    Powles, Thomas
    CLINICAL CANCER RESEARCH, 2021, 27 (12) : 3360 - 3369
  • [45] A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer
    Shore, Neal
    Mellado, Begona
    Shah, Satish
    Hauke, Ralph
    Costin, Dan
    Adra, Nabil
    Cullberg, Marie
    Teruel, Carlos Fernandez
    Morris, Thomas
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 278 - 285
  • [46] A CONSENSUS DEFINITION FOR CASTRATION-RESISTANT PROSTATE CANCER. "DELPHI STUDY"
    Gomez Veiga, Francisco
    Alcaraz, A.
    Bellmunt, J.
    Rodriguez, A.
    Solsona, E.
    JOURNAL OF UROLOGY, 2011, 185 (04) : E259 - E260
  • [47] Metastatic castration-resistant prostate cancer. Position paper for structured therapy monitoring
    Miller, K.
    Albers, P.
    Eichenauer, R.
    Geiges, G.
    Grimm, M. -O.
    Koenig, F.
    Mickisch, G.
    Pfister, D.
    Schwentner, C.
    Suttmann, H.
    Zastrow, S.
    UROLOGE, 2014, 53 (05): : 710 - 714
  • [48] Phase Ib dose escalation study of novel immunogenic cell death (ICD) inducer PT-112 plus PD-L1 inhibitor avelumab in solid tumours
    Karp, D. D.
    Dronca, R. S.
    Camidge, R.
    Costello, B. A.
    Mansfield, A. S.
    Ames, T. D.
    Jimeno, J. M.
    Bryce, A. H.
    ANNALS OF ONCOLOGY, 2020, 31 : S708 - S708
  • [49] Phase II study of the efficacy of abirateron acetate with dutasteride for castration-resistant prostate cancer.
    Matsuyama, Hideyasu
    Shiota, Masaki
    Tashiro, Kojiro
    Kanji, Hiromi
    Horiyama, Shizuyo
    Eto, Masatoshi
    Egawa, Shin
    Haginaka, Jun
    Inoue, Ryo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [50] The association of BMI and PSA density on survival among patients with metastatic or castration-resistant prostate cancer.
    Glaser, Zachary A.
    Avulova, Svetlana
    Stocks, Blair
    Penson, David F.
    Moses, Kelvin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345